title: Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group.
authors.affiliation: Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Lange
authors.forename: K J
authors.initials: KJ
authors.lastname: Felice
authors.forename: B W
authors.initials: BW
authors.lastname: Festoff
authors.forename: M J
authors.initials: MJ
authors.lastname: Gawel
authors.forename: D F
authors.initials: DF
authors.lastname: Gelinas
authors.forename: R
authors.initials: R
authors.lastname: Kratz
authors.forename: E C
authors.initials: EC
authors.lastname: Lai
authors.forename: M F
authors.initials: MF
authors.lastname: Murphy
authors.forename: H M
authors.initials: HM
authors.lastname: Natter
authors.forename: F H
authors.initials: FH
authors.lastname: Norris
authors.forename: S
authors.initials: S
authors.lastname: Rudnicki
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D008297:Male
chemical_list: D007334:Insulin-Like Growth Factor I